• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

How Many Stillbirths Could Be Prevented by Induction in Low-Risk Women at 39 Weeks?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Po et al. (AJOG, 2019) sought to predict the potential reduction in stillbirths with the adoption of the ARRIVE protocol of induction at 39 weeks for nulliparous, low risk women

METHODS:

  • Retrospective study
  • Data sources
    • US vital statistics data from Live Birth and Fetal Death certificates (2014 to 2016)
    • Singleton deliveries ≥39 weeks | No preexisting maternal risk factors
    • Exclusions: Pregestational diabetes | Chronic hypertension | Scheduled cesarean delivery | Unknown delivery method | Unknown gestational age
  • Study design
    • Researchers determined the number of stillbirths in low risk women from 39 weeks on
    • Assumption: Not all stillbirths in the 39th week would be prevented by induction in the 39th week as some stillbirths would have occurred in the 39th week prior to delivery  
      • Authors assumed that half of 39-week stillbirths could be prevented by induction
  • Primary outcome
    • Determine stillbirth rate at ≥39 weeks in singleton, low-risk pregnancies and predict potential impact of the 39-week induction policy
    • Calculate number of inductions required to prevent 1 stillbirth based on the above results

RESULTS:

  • 12,098,773 total births | 155,753 stillbirths
  • At ≥39 weeks, 3874 stillbirths were recorded
    • Low risk: 3584 stillbirths | Stillbirth rate of 0.60 per 1000 births
  • The total number of preventable stillbirths during the 3-year study period was 2650 (883 stillbirths per year)
  • Using ‘conservative’ assumption that only 50% of 39-week stillbirths would be prevented by 39-week induction
    • Total preventable stillbirths with 39 week policy: 2650 (approximately 883 per year)
    • 1675 inductions would be required to prevent 1 stillbirth

CONCLUSION:

  • Implementing the ARRIVE protocol could potentially prevent 883 stillbirths per year in the US; however, 1675 inductions would be required to prevent one stillbirth
  • Authors state that these results could help aid clinicians and patients with decision making

Learn More – Primary Sources:

The impact of induction of labor at 39 weeks in low-risk women on the incidence of stillbirth

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

The ARRIVE Trial and Professional Guidance: Elective 39 Week Induction to Reduce the Risk of Cesarean Section
Induction vs Expectant Management At and Beyond Term – the Cochrane Review
Low-Risk Multiparous Women: Induction of Labor at 39 Weeks or Expectant Management?
Does Elective Induction of Labor at 39 Weeks Gestation Lead to Improved Maternal and Newborn Outcomes?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site